Activation of the complement by immunostimulants, BCG, OK-432 (Picibanil) , and PS-K (Krestin) in vitro
Kondo, M.; Kato, H.; Yokoe, N.; Matsumura, N.; Hotta, T.; Masuda, M.
Gan 69(5): 699-702
1978
ISSN/ISBN: 0016-450X PMID: 729967 Document Number: 132555
Document emailed within 1 workday
Related Documents
Miyamoto, Y. 1986: Clinical study of complement activation during cardiopulmonary bypass--analyses of complement activation pathway and transpulmonary leukosequestration Nihon Kyobu Geka Gakkai 34(12): 2055-2061Shannon, E.J.; Sandoval, F.G.; Morales, M.J. 2011: In vitro thalidomide does not interfere with the activation of complement by M. leprae Journal of drugs in dermatology: JDD 10(3): 274-278
Kovalev, B.M.; Nazarova, I.V.; Khotimchenko, I.S. 1998: Methods of in vitro assessment of the degree of complement activation by the classical pathway Klinicheskaia Laboratornaia Diagnostika 1998(1): 34-37
Videm, V.; Fosse, E.; Mollnes, T.E.; Ellingsen, O.; Pedersen, T.; Karlsen, H. 1989: Different oxygenators for cardiopulmonary bypass lead to varying degrees of human complement activation in vitro Journal of Thoracic and Cardiovascular Surgery 97(5): 764-770
Wuillemin, W.A.; te Velthuis, H.; Lubbers, Y.T.; de Ruig, C.P.; Eldering, E.; Hack, C.E. 1997: Potentiation of C1 inhibitor by glycosaminoglycans: dextran sulfate species are effective inhibitors of in vitro complement activation in plasma Journal of Immunology 159(4): 1953-1960
Jurd, K.M.; Lee, J.; Cairns, T.; Hunt, B.J. 1996: Effect of Gal alpha 1,3 Gal-beta 1,4 GlcNAc and complement depletion on haemostatic activation in an in vitro model of the pig-to-human xenograft reaction Transplantation Proceedings 28(2): 637-638
Kovalev, B.M. 1988: An index of complement activation in the body--a new approach to the evaluation of the functional state of the complement system in man in normal and in pathological conditions Laboratornoe delo 1988(6): 65-67
Lint, T.F. 1982: Laboratory detection of complement activation and complement deficiencies American Journal of Medical Technology 48(9): 743-748
Gale, R.J.; Nikoloutsopoulos, A.; Bradley, J.; Roberts-Thomson, P.J. 1985: Immune complex activation of neutrophils and enhancement of the activation by rheumatoid factor and complement Journal of Rheumatology 12(1): 21-26
Mold, C.; Gewurz, H. 1980: Activation of human complement by liposomes: serum factor requirement for alternative pathway activation Journal of Immunology 125(2): 696-700
1985: Complement activation during hemodialysis New England Journal of Medicine 312(8): 513-516
Remington, D.L.; Freed, D.L.; Banks, A.J. 1984: Complement activation after hip replacement operations Journal of the Royal College of Surgeons of Edinburgh 29(6): 357
Fine, R.M. 1977: Complement system activation by contrast media International Journal of Dermatology 16(10): 830
Becker, P.; Zieger, S.; Rother, U.; Lutz, H.; Osswald, P.M. 1987: Complement activation following head and brain trauma Der Anaesthesist 36(6): 301-305
Nicholson, A.; Brade, V.; Schorlemmer, H.U.; Burger, R.; Bitter-Suermann, D.; Hadding, U. 1975: Interaction of C3b, B, and D in the alternative pathway of complement activation Journal of Immunology 115(4): 1108-1113
Etievant, M. 1973: Alternate pathway activation of the complement system Pathologie-Biologie 21(8): 895-900
Munoz, L.E.; De Villiers, D.; Markham, D.; Whaley, K.; Thomas, H.C. 1982: Complement activation in chronic liver disease Clinical and Experimental Immunology 47(3): 548-554
Ruddy, S.; Austen, K.F. 1973: Activation of the complement system in rheumatoid synovitis Federation Proceedings 32(2): 134-137
Kubatiev, A.; Rudko, I.; Ermolenko, V. 1993: Complement activation and neutrophil aggregation changes during haemodialysis International Journal of Clinical Pharmacology Research 13(6): 293-299
Di Perri, T.; Auteri, A.; Pasini, F.L.; Mattioli, F. 1977: Inhibition by cinnarizine of the properdin-dependent activation of complement Archives Internationales de Pharmacodynamie et de Therapie 226(2): 281-285